Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea
· Delayed Price · Currency is KRW 2,680.00
+615.00 (29.78%)
At close: Jun 26, 2025, 3:30 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 43.27 billion as of June 27, 2025. Its market cap has decreased by -17.39% in one year.
Market Cap
43.27B
Enterprise Value
28.96B
Revenue
11.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,680.00
Market Cap Chart
Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 43.27B, a decrease of -85.58%. That is a compound annual growth rate of -29.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 391.17T |
| SK hynix | 196.06T |
| Samsung Biologics | 71.46T |
| LG Energy Solution | 67.39T |
| Hyundai Motor Company | 45.04T |
| Hanwha Aerospace | 41.99T |
| Doosan Enerbility | 39.07T |
| Kia Corporation | 38.55T |